These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17329266)

  • 1. Voriconazole concentrations in synovial fluid and bone tissues.
    Denes E; Boumediene A; Durox H; Oksman A; Saint-Marcoux F; Darde ML; Gaulier JM
    J Antimicrob Chemother; 2007 Apr; 59(4):818-9. PubMed ID: 17329266
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
    MacCallum DM; Whyte JA; Odds FC
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3697-701. PubMed ID: 16127042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of voriconazole in Japanese quail (Coturnix japonica) experimentally infected with Aspergillus fumigatus.
    Tell LA; Clemons KV; Kline Y; Woods L; Kass PH; Martinez M; Stevens DA
    Med Mycol; 2010 Mar; 48(2):234-44. PubMed ID: 19548171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections.
    Boyd NK; Zoellner CL; Swancutt MA; Bhavan KP
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6001-2. PubMed ID: 22890768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of voriconazole in the cerebrospinal fluid of an immunocompromised patient with a brain abscess due to Aspergillus fumigatus.
    Denes E; Pichon N; Debette-Gratien M; Bouteille B; Gaulier JM
    Clin Infect Dis; 2004 Aug; 39(4):603-4. PubMed ID: 15356837
    [No Abstract]   [Full Text] [Related]  

  • 6. Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.
    Stern JB; Girard P; Caliandro R
    Antimicrob Agents Chemother; 2004 Mar; 48(3):1065. PubMed ID: 14982812
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
    Clifton IJ; Whitaker P; Metcalfe R; Phillip M; Shaw N; Conway SP; Peckham DG
    J Antimicrob Chemother; 2011 Oct; 66(10):2438-40. PubMed ID: 21791443
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis.
    Jeans AR; Howard SJ; Al-Nakeeb Z; Goodwin J; Gregson L; Warn PA; Hope WW
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5180-5. PubMed ID: 22825124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints.
    Jeans AR; Howard SJ; Al-Nakeeb Z; Goodwin J; Gregson L; Majithiya JB; Lass-Flörl C; Cuenca-Estrella M; Arendrup MC; Warn PA; Hope WW
    J Infect Dis; 2012 Aug; 206(3):442-52. PubMed ID: 22634880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of voriconazole.
    Levêque D; Nivoix Y; Jehl F; Herbrecht R
    Int J Antimicrob Agents; 2006 Apr; 27(4):274-84. PubMed ID: 16563707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological aspects of the new triazole voriconazole.
    Ullmann AJ
    Ann Hematol; 2002; 81 Suppl 2():S50-1. PubMed ID: 12611077
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.
    Krishnan-Natesan S; Chandrasekar PH; Alangaden GJ; Manavathu EK
    Int J Antimicrob Agents; 2008 Dec; 32(6):519-24. PubMed ID: 18775650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole. UK 109496.
    Drugs R D; 1999 Feb; 1(2):187-8. PubMed ID: 10566023
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation.
    Brüggemann RJ; Antonius T; Heijst Av; Hoogerbrugge PM; Burger DM; Warris A
    Ther Drug Monit; 2008 Dec; 30(6):643-6. PubMed ID: 19057370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD; Kiraz N
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of voriconazole in seven body fluids of adult horses after repeated oral dosing.
    Passler NH; Chan HM; Stewart AJ; Duran SH; Welles EG; Lin HC; Ravis WR
    J Vet Pharmacol Ther; 2010 Feb; 33(1):35-41. PubMed ID: 20444023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy and pharmacokinetics of voriconazole in an animal model of dermatophytosis.
    Saunte DM; Simmel F; Frimodt-Moller N; Stolle LB; Svejgaard EL; Haedersdal M; Kloft C; Arendrup MC
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3317-21. PubMed ID: 17576826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple-triazole-resistant aspergillosis.
    Verweij PE; Mellado E; Melchers WJ
    N Engl J Med; 2007 Apr; 356(14):1481-3. PubMed ID: 17409336
    [No Abstract]   [Full Text] [Related]  

  • 19. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
    Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J
    Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.